BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. FGF21, G-protein-coupled receptor binding, Breast Cancer, Breast, Biofuel, Lovastatin)
Bookmark Forward

QuickView for non coding rnas (compound)


Genetic Markers

Most Correlated Genes

  1. IFI44L
  2. IFIT1
  3. HMOX1
  4. MX1
  5. INHBE
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. NUYTTEN_EZH2_TARGETS_UP
  2. MURARO_PANCREAS_DUCTAL_CELL
  3. DODD_NASOPHARYNGEAL_CARCINOMA_DN
  4. regulation of nitrogen compound metabolic process
  5. response to stress
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Articular chondrocyte C-28I2 cells with shRNA mediated CA2 knockdown
  2. Human vulval carcinoma fibroblasts (VCAF8) cells with TFAP2C siRNA knockdown
  3. Cervical carcinoma HeLa cells with CRISPR-CAS13d mediated targeting of DMPK CUG repeat
  4. Cervical carcinoma HeLa cells with MYC siRNA or UBR5 siRNA knockdown
  5. CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Non-coding RNAs with essential roles in neurodegenerative disorders.
  2. Novel classes of non-coding RNAs and cancer.
  3. Non-coding RNAs in Alzheimer's disease.
  4. Relevance of long non-coding RNAs in tumour biology].
  5. Long non-coding RNAs and their relevance in cancer].
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer
  2. Study of Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis Biomarker for Acute Pancreatiti…
  3. The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocell…
  4. Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)
  5. Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.